Fulcrum Therapeutics Reports Recent Business Highlights and First Quarter 2022 Financial Results

Go back to Fulcrum Therapeutics Reports Recent Business Highlights and First Quarter 2022 Financial Results
(NASDAQ: FULC) Delayed: 3.70 +0.20 (5.71%)
Previous Close $3.50    52 Week High
Open $3.56    52 Week Low
Day High $3.71    P/E N/A 
Day Low $3.46    EPS
Volume 6,101,106